Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 302 participants.

Also called NCT01253200

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 302 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01253200
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01253200. Randomized; single masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2013-09 (actual). Results posted on 2018-02-15.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
Acronym
BLOCk-CTI
Intervention (Device)
Blazer® Open-Irrigated Ablation Catheter
Intervention (Device)
Control Catheter
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct01253200
Content hash
e13f2bc8211e8e4e17c0e9c7f216e5d362321120d4175e2013fe8f91c1f59f1e